As a result of these IL-6-promoted effects in the CNS, the concentrations of glucocorticoids in depression could be increased38–43 and contributing finally to the development of several clinical manifestations of mood disorders, such as fatigue43. This evidence concerns the gene IL6 and depressive symptom measurement.